As 12 countries worldwide legalize voluntary euthanasia, a critical question emerges for transplantation medicine: can the foundational dead donor rule adapt to this new reality? A New England Journal of Medicine analysis examines how Belgium, the Netherlands, and Canada are navigating this intersection of patient autonomy and organ procurement ethics.
The dead donor rule, established in the 1960s and codified in U.S. law through the Uniform Determination of Death Act (1981), mandates that organ donation cannot accelerate or cause a patient’s death. Yet jurisdictions permitting medical assistance in dying face unprecedented ethical tensions: balancing individual autonomy with organ scarcity, preventing coercion of vulnerable populations, and maintaining public confidence in medical institutions.
Regulatory frameworks across these nations reveal divergent approaches to reconciling these competing values. Each model emphasizes critical safeguards—team separation, ethical review processes, and transparent oversight—to preserve the integrity of both euthanasia protocols and transplantation systems. Medical ethics experts stress that maintaining public trust remains paramount as these frameworks continue to evolve.
Read the full article on GMJ Newsroom.
Was this article helpful?
